Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-24

Clinical Trial Update: Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Sevikar with perindopril/amlodipine on central blood pressure in hypertension patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perindopril/amlodipine (perindopril/amlodipine)
  • Sevikar

Snippet

Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | Conditions: Hypertension | Phase 4 | Status: COMPLETED